Morning Overview on MSN
A new non-stimulant ADHD medication just won FDA approval
Attention-deficit/hyperactivity disorder has long been treated mainly with stimulants, and the handful of non-stimulant ...
The U.S. Food and Drug Administration has approved Simtriyo (centanafadine) for the treatment of ...
Cognitive behavioral therapy (CBT) is a vetted, evidence-based psychosocial treatment for adult ADHD. Such evidence-based status is established chiefly by way of randomized controlled clinical trials.
Welltica+ on MSN
Experts call for changes to ADHD treatment after new research
Experts are calling for changes to ADHD care as new research raises questions about medication safety.
Increased public awareness of ADHD, better diagnostic care and the availability of new and improved medications may all ...
Australia is loosening regulations so that general practitioners (GPs) can meet the growing demand for attention-deficit/hyperactivity disorder (ADHD) care. But some ...
Adult Attention-Deficit/Hyperactivity Disorder (ADHD) and Generalised Anxiety Disorder (GAD) are both very common mental ...
Attention deficit hyperactivity disorder (ADHD) is a risk factor for co-occurring psychiatric disorders and negative psychosocial consequences in adulthood. Previous trials of psychotherapeutic ...
New research reveals ADHD isn't one-size-fits-all — covering social media's specific role, why medication rarely 'stops ...
Diagnoses for attention deficit hyperactivity disorder (ADHD) have increased in many countries across all age groups, our ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results